Syngene International Limited has informed the Exchange regarding a press release dated April 29, 2026, titled "Full-year revenue from operations up 3% to Rs. 3,739 Cr; Fourth quarter revenue from operations up 2% year-on-year to Rs. 1,037 Cr.".
Press Release Apr 29 2026
Earlier from Syngene International
- Biodexa Announces Partnership with Syngene To Manufacture MTX240 GMP Clinical Trial Supplies
- VivaMed BioPharma Partners With Syngene International to Advance AI-Derived Repurposed Therapeutic Programs Through Global Validation Infrastructure
- Press Release Jan 22 2026
- Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035